พบ "Public health policy"ทั้งหมด 1,272 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
วันที่อัปเดตล่าสุด
Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia
Abstract
Planning and administering Universal Health Coverage (UHC) policies involve complex and critical decisions, especially in resource-scarce and densely populated settings such as Indonesia. Increasing investments alone do not ensure success and sustainability of UHC, and defining prioritie
Prioritizing critical-care resources in response to COVID-19: lessons from the development of Thailand’s Triage protocol
Abstract
As COVID-19 ravages the world, many countries are faced with the grim reality of not having enough critical-care resources to go around. Knowing what could be in store, the Thai Ministry of Public Health called for the creation of an explicit protocol to determine how these resources are
Reducing sedentary behaviour and physical inactivity in the workplace: protocol for a review of systematic reviews
Abstract
Background and objective
Increasing rates of urbanisation have been accompanied by higher levels of sedentary behaviour (SB) and reduced physical activity (PA) worldwide. While physical inactivity has long been identified as a major risk factor for morbidity and mortality, increased c
The physical activity at work (PAW) study protocol: a cluster randomised trial of a multicomponent short-break intervention to reduce sitting time and increase physical activity among office workers in Thailand
Abstract
Background: High levels of sedentary behaviour (SB) are associated with non-communicable diseases. In 2016, the estimated total healthcare expenditure from physical activity (PA) in Thailand added up to $190 million in international dollars. The challenge to reduce SB and increase PA amo
Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines
Abstract
Aim
Kidney failure patients in the Philippines have free choice on their kidney replacement therapy (KRT), with a majority choosing haemodialysis (HD) over peritoneal dialysis (PD) and transplantation despite the inadequate coverage of HD. Although national health insurance coverage is
Charging for the use of survey instruments on population health: the case of quality-adjusted life years
Abstract
A trend towards charging for access to research findings, tools and databases is becoming more prominent globally. But charging for the use of research tools and databases that are vital to research supporting national and international policy development might be unjustified. Financial
A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region
Abstract
Background
Progress towards achieving Universal Health Coverage and institutionalizing healthcare priority setting through health technology assessment (HTA) in the Association of South-East Asian Nations (ASEAN) region varies considerably across countries because of differences in heal
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Summary
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 20
Co-production of evidence for policies in Thailand: from concept to action
KEY MESSAGES
• Thailand uses co-production of evidence, based on the concept of the “triangle that moves the mountain,” to support health policy making
• The annual national health assembly is a key platform for interactions between multiple stakeholders to adopt resolutions through consensus
•
Using health technology assessment to set priority, inform target product profiles, and design clinical study for health innovation
Abstract
Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa
10 / หน้า